INVO Reports Record First Quarter 2024 Financial Results SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

INVO Reports Fourth Quarter and Full Year 2023 Financial Results SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SRT, ESMT, NM, INVO NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...

ALERT: The M&A Class Action Firm Continues Investigating the Merger – ESMT, NM, INVO, PXD NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...

Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...